Cargando…
Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy
This study aimed to evaluate the clinical outcomes of patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma (LSCC) treated with laryngectomy, and to assess the postoperative radiotherapy (PORT) results in terms of the survival of T3-T4aN0M0 patients with negative margins. This was a retr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608082/ https://www.ncbi.nlm.nih.gov/pubmed/36311684 http://dx.doi.org/10.3892/ol.2022.13554 |
_version_ | 1784818697817292800 |
---|---|
author | Zhou, Jian Heng, Yu Yang, Yue Zhu, Xiaoke Zhou, Liang Gong, Hongli Xu, Chengzhi Tao, Lei |
author_facet | Zhou, Jian Heng, Yu Yang, Yue Zhu, Xiaoke Zhou, Liang Gong, Hongli Xu, Chengzhi Tao, Lei |
author_sort | Zhou, Jian |
collection | PubMed |
description | This study aimed to evaluate the clinical outcomes of patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma (LSCC) treated with laryngectomy, and to assess the postoperative radiotherapy (PORT) results in terms of the survival of T3-T4aN0M0 patients with negative margins. This was a retrospective review of 369 T3-4aN0M0 glottic LSCC cases. The 5-year cancer-specific survival (CSS) and overall survival (OS) rates were 67.5 and 66.7%, respectively. Patients who received total laryngectomy had worse survival [5-year CSS, 62.5%; disease-free survival (DFS), 56.2%] than those who underwent partial laryngectomy (5-year CSS, 79.3%; DFS, 65.4%). More advanced-stage cancer is a predictor of poor survival. There was no significant difference in CSS or DFS between patients with positive margins following rescue therapy and those with negative margins. Furthermore, no difference in the survival rates was observed between patients with negative margins who received PORT and those who did not (5-year DFS: 59.1 vs. 63.8%, P=0.057 and CSS: 62.5 vs. 69.5%, P=0.074). For T3-4aN0M0 glottic LSCC patients, surgical treatment remained a good option, as it can achieve satisfactory oncological outcomes. However, PORT did not increase survival in surgically managed pT3-4aN0M0 LSCC patients with negative margins. |
format | Online Article Text |
id | pubmed-9608082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-96080822022-10-28 Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy Zhou, Jian Heng, Yu Yang, Yue Zhu, Xiaoke Zhou, Liang Gong, Hongli Xu, Chengzhi Tao, Lei Oncol Lett Articles This study aimed to evaluate the clinical outcomes of patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma (LSCC) treated with laryngectomy, and to assess the postoperative radiotherapy (PORT) results in terms of the survival of T3-T4aN0M0 patients with negative margins. This was a retrospective review of 369 T3-4aN0M0 glottic LSCC cases. The 5-year cancer-specific survival (CSS) and overall survival (OS) rates were 67.5 and 66.7%, respectively. Patients who received total laryngectomy had worse survival [5-year CSS, 62.5%; disease-free survival (DFS), 56.2%] than those who underwent partial laryngectomy (5-year CSS, 79.3%; DFS, 65.4%). More advanced-stage cancer is a predictor of poor survival. There was no significant difference in CSS or DFS between patients with positive margins following rescue therapy and those with negative margins. Furthermore, no difference in the survival rates was observed between patients with negative margins who received PORT and those who did not (5-year DFS: 59.1 vs. 63.8%, P=0.057 and CSS: 62.5 vs. 69.5%, P=0.074). For T3-4aN0M0 glottic LSCC patients, surgical treatment remained a good option, as it can achieve satisfactory oncological outcomes. However, PORT did not increase survival in surgically managed pT3-4aN0M0 LSCC patients with negative margins. D.A. Spandidos 2022-10-19 /pmc/articles/PMC9608082/ /pubmed/36311684 http://dx.doi.org/10.3892/ol.2022.13554 Text en Copyright: © Zhou et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Zhou, Jian Heng, Yu Yang, Yue Zhu, Xiaoke Zhou, Liang Gong, Hongli Xu, Chengzhi Tao, Lei Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy |
title | Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy |
title_full | Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy |
title_fullStr | Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy |
title_full_unstemmed | Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy |
title_short | Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy |
title_sort | survival outcomes in patients with t3-4an0m0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608082/ https://www.ncbi.nlm.nih.gov/pubmed/36311684 http://dx.doi.org/10.3892/ol.2022.13554 |
work_keys_str_mv | AT zhoujian survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy AT hengyu survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy AT yangyue survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy AT zhuxiaoke survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy AT zhouliang survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy AT gonghongli survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy AT xuchengzhi survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy AT taolei survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy |